drugset

drugset / Trial / NCT00398294

To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)

NCT00398294 ↗

Phase 4 Completed 30 enrolled Organon and Co

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia.

Timeline

Start: 2005-05-01
Primary completion: 2006-04-04
Completion: 2006-04-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Simvastatin	Small molecule	40 mg	—

Indications